Angiotech Pharmaceuticals to participate in Deutsche Bank Conference
26 April 2005 - 11:05PM
PR Newswire (US)
Angiotech Pharmaceuticals to participate in Deutsche Bank
Conference VANCOUVER, April 26 /PRNewswire-FirstCall/ -- Angiotech
Pharmaceuticals, Inc. (NASDAQ:ANPINASDAQ:TSX:NASDAQ:ANP), is
scheduled to participate in the 30th Annual Deutsche Bank
Healthcare Conference. Rui Avelar, Senior Vice President, Medical
Affairs and Communications of Angiotech, will be making a 25-minute
presentation at the conference on Tuesday, May 3rd, 2005 at 4:00 pm
EST (1:00 pm PST). A live audio only webcast of Dr. Avelar's
remarks will be available to all interested parties at Angiotech's
website at http://www.angiotech.com/ in the Investor Relations
section. To ensure a timely connection to the webcast, it is
recommended that users register at least 15 minutes before the
webcast begins. Vancouver-based Angiotech Pharmaceuticals, Inc. is
a specialty pharmaceutical company pioneering the combination of
pharmaceutical compounds with medical devices and biomaterials to
both create novel solutions for challenging disease states and
advance surgical outcomes. To find out more about Angiotech
Pharmaceuticals, Inc. (NASDAQ:ANPINASDAQ:TSX:NASDAQ:ANP), please
visit our website at http://www.angiotech.com/ . CONTACTS: Todd
Young, Angiotech Pharmaceuticals (Analysts & Investors) (604)
221-7676 ext 6933 Rui Avelar, Angiotech Pharmaceuticals, Inc.
(Analysts) (604) 221-7676 ext 6996 Eric Starkman, Starkman &
Associates (Media) (212) 252-8545 ext 12 DATASOURCE: Angiotech
Pharmaceuticals, Inc. CONTACT: Todd Young, Angiotech
Pharmaceuticals (Analysts & Investors), (604) 221-7676 ext
6933; Rui Avelar, Angiotech Pharmaceuticals, Inc. (Analysts), (604)
221-7676 ext 6996; Eric Starkman, Starkman & Associates
(Media), (212) 252-8545 ext 12
Copyright
Angiotech Pharmaceuticals - Common Shares (MM) (NASDAQ:ANPI)
Historical Stock Chart
Von Jun 2024 bis Jul 2024
Angiotech Pharmaceuticals - Common Shares (MM) (NASDAQ:ANPI)
Historical Stock Chart
Von Jul 2023 bis Jul 2024
Echtzeit-Nachrichten über Angiotech Pharmaceuticals - Common Shares (MM) (NASDAQ): 0 Nachrichtenartikel
Weitere Angiotech Pharmaceuticals - Common Shares (MM) News-Artikel